Intranasal steroids and the risk of emergency department visits for asthma

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 4, 2002, Pages 636-642

  Adams, Robert J ^a   Fuhlbrigge, Anne L ^b   Finkelstein, Jonathan A ^c   Weiss, Scott T ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Asthma; Outcome assessment; Rhinitis; Therapeutics

Indexed keywords

ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ADOLESCENT; ADULT; AGED; ALLERGIC ASTHMA; ALLERGIC RHINITIS; AMBULATORY CARE; ARTICLE; CHILD; COHORT ANALYSIS; CONSULTATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMERGENCY WARD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; OTITIS MEDIA; PRESCRIPTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; SINUSITIS;

EID: 0036227910     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.123237     Document Type: Article

References (49)

1. Overview of comorbid associations of allergic rhinitis
2. Epidemiology of rhinitis and asthma
3. Allergic and non-allergic rhinitis: Their characterisation with attention to the meaning of nasal eosinophilia
4. Rhinitis is ubiquitous in allergic asthmatics
5. Increase of asthma and allergic rhinitis prevalence in young Italian men
6. Perennial rhinitis: An independent risk factor for asthma in non-atopic subjects
7. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia
8. Allergy in patients with acute maxillary sinusitis
9. Extrathoracic and intrathoracic airway responsiveness in sinusitis
10. The role of antihistamines in otitis
11. The role of IgE-mediated hypersensitivity in the development of otitis media with effusion
12. The role of nasal allergy in otitis media with effusion: A clinical study
13. Otitis media and chronic middle ear effusion in the asthmatic pediatric patient
14. Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion
15. Eustachian tube dysfunction after histamine nasal provocation
16. Asthma and rhinitis: Management implications
17. Allergic rhinobronchitis: The asthma-allergic rhinitis link
18. Allergic rhinitis in Rochester, Minnesota residents with asthma: Frequency and impact on healthcare charges
19. Efficacy of beclomethasone nasal solution, flunisolide and cromolyn in relieving symptoms of ragweed
20. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma
21. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma
22. Once daily intranasal fluticasone propionate (200 mg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis
23. Nasal inhalation of the glucocorticoid budesonide from a spacer for the treatment of patients with pollen rhinitis and asthma
24. Efficacy and safety of loratidine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma
25. Clinical aspects of disease. Cetrizine in patients with seasonal rhinitis and concomitant asthma: Prospective, randomized, placebo-controlled trial
26. Rhinitis and asthma: Treatment options
27. Post-marketing studies of drug efficacy: Why?
28. Post-marketing studies of drug efficacy: How?
29. Inhaled steroids and the risk of hospitalisation for asthma
30. Diagnosis in rhinitis coexisting with asthma
31. Patterns of increasing beta-agonist use and the risk of fatal or near-fatal asthma
32. Pharmaceutically-based severity stratification of an asthmatic population
33. Physicians' knowledge of NIH asthma treatment guidelines
34. Allergic rhinitis and asthma: How important is the link?
35. Different effects of nasal and bronchial glucocorticosteroid administration on bronchial hyperresponsiveness in patients with allergic rhinitis
36. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: Effect on lower airway responsiveness
37. Epidemiology of physician diagnosed allergic rhinitis in childhood
38. As-needed use of fluticasone propionate nasal sprays reduces symptoms of seasonal allergic rhinitis
39. Absence of growth retardation in children with perennial allergic rhinitis following I year of treatment with mometasone furoate aqueous spray
40. Comparative efficacy of terfenadine, loratidine, and astemizole in perennial allergic rhinitis
41. Model for outcome assessment of antihistamine use for seasonal allergic rhinitis
42. Optimizing quality of care and cost-effectiveness in treating allergic rhinitis in a managed care setting
43. Inhaled corticosteroid use and bone-mineral density in patients with asthma
44. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate
45. A review of the preclinical and clinical data of the newer intranasal steroids used in the treatment of allergic rhinitis
46. Intranasal corticosteroids for allergic rhinitis: How do different agents compare?
47. Targeted intervention programs: Creating a customized practice model to improve the treatment of allergic rhinitis in a managed care population